TMS vs. Ketamine for Treatment-Resistant Depression: How to Compare the Options

Two different approaches to difficult depression

When several antidepressants have not helped enough, patients often hear about transcranial magnetic stimulation (TMS), ketamine infusions and Spravato. They are not interchangeable treatments. They differ in how they are delivered, how long appointments take, how patients are monitored and what insurance may cover. Understanding those differences helps you ask better questions during a psychiatric consultation.


How TMS works

TMS uses magnetic pulses delivered through a device positioned near the scalp to stimulate specific brain regions involved in mood regulation. It does not require anesthesia or produce the medication effects associated with ketamine. A course typically involves repeated office visits over several weeks, although protocols vary by device and indication. Many patients can resume normal daily activities after a standard session, subject to their clinician's instructions.


How ketamine differs

Ketamine acts primarily through glutamate-related pathways, including NMDA receptor signaling. IV ketamine is FDA-approved as an anesthetic, but its use for depression is off-label. Infusions require medical assessment and monitoring, and patients need transportation afterward. Some studies show rapid antidepressant effects, but the duration of response varies and maintenance approaches are not standardized across clinics.


Where Spravato fits

Spravato contains esketamine and is FDA-approved for specified depressive indications. It is self-administered under supervision at a REMS-certified healthcare setting, with at least two hours of monitoring afterward. Patients cannot drive until the next day after a restful sleep. Its structured dosing schedule and insurance process differ from those of off-label IV ketamine. Approval does not guarantee that an insurer will authorize treatment for every patient.


Which works faster?

Some patients experience antidepressant improvement soon after ketamine or esketamine treatment, while TMS often requires multiple sessions before benefit becomes apparent. Individual outcomes vary. Speed alone is a poor basis for choosing treatment: medical suitability, durability, side effects, availability and the treatment history matter too. Neither option should be described as a guaranteed cure.


What are the main safety differences?

TMS may cause scalp discomfort or headache and has a rare seizure risk. Screening is important for certain implanted metal or electronic devices. Ketamine and Spravato can cause sedation, dissociation and temporary blood-pressure increases; monitoring and post-treatment transportation are essential. A clinician should review medical conditions, medications, substance-use history and psychiatric diagnoses before recommending any option.


How do costs and insurance compare?

Coverage depends on diagnosis, medical-necessity criteria, provider participation, prior authorization and the individual plan. FDA-cleared TMS protocols and FDA-approved Spravato may have insurance pathways when criteria are met. Off-label IV ketamine for depression is often paid out of pocket. Ask for an individualized benefits verification and a written explanation of expected charges rather than relying on general statements that a clinic accepts insurance.


Can people try both?

Some patients discuss one approach after an inadequate response to another, but there is no universal sequence appropriate for everyone. Combination or sequential treatment decisions should be made with a qualified clinician who understands the patient's diagnosis and treatment history. Do not discontinue existing medication or psychotherapy without medical guidance.


Choosing based on your actual circumstances

Consider the number of visits, whether you can arrange rides, your work schedule, medical contraindications and prior treatment experience. Ask what outcome will be measured, when response will be reassessed and what happens if the first plan is ineffective. A good consultation makes uncertainty visible instead of overselling a single option.


A conversation worth having

KetaRevive offers IV ketamine and Spravato in Wyckoff, NJ; this article does not imply that KetaRevive provides TMS. Patients comparing these options can discuss their prior depression treatments with their mental-health clinician and ask whether referral for TMS evaluation, Spravato assessment or another strategy makes the most sense.

Next
Next

What Happens If You Miss a Spravato Treatment? Understanding Schedule Changes